Dashboard
Manage Tickers

FLGTFulgent Genetics, Inc.

Nasdaq fulgentgenetics.com


$ 21.22 $ 0.54 (2.61 %)    

Thursday, 02-May-2024 15:59:51 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 433.87 $ 1.55 (0.36 %)
DIA $ 382.31 $ 3.34 (0.88 %)
SPY $ 510.53 $ 0.00 (0 %)
TLT $ 89.84 $ -0.27 (-0.3 %)
GLD $ 213.41 $ -0.01 (-0 %)
$ 21.24
$ 20.89
$ 21.21 x 200
$ 21.24 x 200
$ 20.64 - $ 21.31
$ 19.88 - $ 44.09
164,028
na
632.61M
$ 1.31
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-03-2024 03-31-2024 10-Q
2 02-28-2024 12-31-2023 10-K
3 11-03-2023 09-30-2023 10-Q
4 08-04-2023 06-30-2023 10-Q
5 05-05-2023 03-31-2023 10-Q
6 02-28-2023 12-31-2022 10-K
7 11-07-2022 09-30-2022 10-Q
8 08-04-2022 06-30-2022 10-Q
9 05-05-2022 03-31-2022 10-Q
10 02-28-2022 12-31-2021 10-K
11 11-09-2021 09-30-2021 10-Q
12 08-09-2021 06-30-2021 10-Q
13 05-07-2021 03-31-2021 10-Q
14 03-08-2021 12-31-2020 10-K
15 11-09-2020 09-30-2020 10-Q
16 08-05-2020 06-30-2020 10-Q
17 05-06-2020 03-31-2020 10-Q
18 03-13-2020 12-31-2019 10-K
19 11-08-2019 09-30-2019 10-Q
20 08-12-2019 06-30-2019 10-Q
21 05-10-2019 03-31-2019 10-Q
22 03-22-2019 12-31-2018 10-K
23 11-09-2018 09-30-2018 10-Q
24 08-13-2018 06-30-2018 10-Q
25 05-14-2018 03-31-2018 10-Q
26 03-20-2018 12-31-2017 10-K
27 11-13-2017 09-30-2017 10-Q
28 08-14-2017 06-30-2017 10-Q
29 05-09-2017 03-31-2017 10-Q
30 03-17-2017 12-31-2016 10-K
31 11-14-2016 09-30-2016 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

fulgent-forecasts-2024-core-revenue-of-approximately-280m-versus-consensus-of-279356m-with-adjusted-eps-loss-of-approximately-105-versus-consensus-of-106
Fulgent Forecasts 2024 Core Revenue Of App...
05/03/2024 11:05:03

fulgent-genetics-q1-2024-adj-eps-001-may-not-be-comparable-to-032-estimate-sales-64485m-miss-65363m-estimate
Fulgent Genetics Q1 2024 Adj EPS $(0.01) M...
05/03/2024 11:02:36

Fulgent Genetics (NASDAQ:FLGT) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(0....

piper-sandler-maintains-neutral-on-fulgent-genetics-lowers-price-target-to-25
Piper Sandler Maintains Neutral on Fulgent...
03/06/2024 14:31:38

Piper Sandler analyst David Westenberg maintains Fulgent Genetics (NASDAQ:FLGT) with a Neutral and lowers the price target f...

fulgent-genetics-expects-2024-core-revenue-of-approximately-280m-versus-consensus-of-29425m-with-adjusted-eps-loss-of-approximately-105-versus-consensus-of-095
Fulgent Genetics Expects 2024 Core Revenue...
02/28/2024 12:05:29

fulgent-genetics-q4-adjusted-eps-028-may-not-be-comparable-to-029-estimate-sales-7050m-beat-6632m-estimate
Fulgent Genetics Q4 Adjusted EPS $0.28 May...
02/28/2024 12:02:51

earnings-scheduled-for-february-28-2024
Earnings Scheduled For February 28, 2024
02/28/2024 11:24:02

Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings at $0.08 per share on revenu...

Core News & Articles
CooperSurgical Partners With Fulgent Genet...
02/09/2024 13:38:59

Testing offers CBR families the opportunity to proactively seek additional information about their child's health

ubs-initiates-coverage-on-fulgent-genetics-with-neutral-rating-announces-price-target-of-35
UBS Initiates Coverage On Fulgent Genetics...
12/07/2023 11:06:04

UBS analyst Dan Leonard initiates coverage on Fulgent Genetics (NASDAQ:FLGT) with a Neutral rating and announces Price Targe...

fulgent-sees-fy23-core-revenue-260m-vs-26066m-estimate-adj-eps-095-vs-109-estimate
Fulgent Sees FY23 Core Revenue $260M Vs $2...
11/03/2023 11:27:49

earnings-scheduled-for-november-3-2023
Earnings Scheduled For November 3, 2023
11/03/2023 11:12:01

Companies Reporting Before The Bell • Arcutis Biotherapeutics (NASDAQ:ARQT) is expected to report quarterly loss at $0.86 per ...

fulgent-q3-2023-eps-039-misses-033-estimate-revenue-66m-beats-634m-estimate
Fulgent Q3 2023 EPS $(0.39) Misses $(0.33)...
11/03/2023 11:04:09

earnings-preview-fulgent-genetics
Earnings Preview: Fulgent Genetics
11/02/2023 17:00:55

piper-sandler-maintains-neutral-on-fulgent-genetics-lowers-price-target-to-28
Piper Sandler Maintains Neutral on Fulgent...
10/16/2023 17:25:23

Piper Sandler analyst David Westenberg maintains Fulgent Genetics (NASDAQ:FLGT) with a Neutral and lowers the price target f...

stocks-that-hit-52-week-lows-on-wednesday
Stocks That Hit 52-Week Lows On Wednesday
10/04/2023 16:01:17

  On Wednesday, 311 stocks hit new 52-week lows.

stocks-that-hit-52-week-lows-on-monday
Stocks That Hit 52-Week Lows On Monday
10/02/2023 17:00:10

  On Monday, 369 companies set new 52-week lows.

10-health-care-stocks-with-whale-alerts-in-todays-session
10 Health Care Stocks With Whale Alerts In...
09/29/2023 17:35:27

stocks-that-hit-52-week-lows-on-thursday
Stocks That Hit 52-Week Lows On Thursday
09/28/2023 18:32:08

  During Thursday's session, 406 companies made new 52-week lows.

stocks-that-hit-52-week-lows-on-thursday
Stocks That Hit 52-Week Lows On Thursday
09/21/2023 16:08:37

  During the session on Thursday, 461 stocks hit new 52-week lows.

why-is-fulgent-genetics-stock-moving-higher-today
Why Is Fulgent Genetics Stock Moving Highe...
08/04/2023 17:20:02

Fulgent Genetics Inc (NASDAQ: FLGT) reported Q2 sales of $68 million, beating the consensus estimate of $62.68 million.<

fulgent-sees-q3-fy23-sales-of-approximately-65m-vs-consensus-of-6284m
Fulgent Sees Q3 FY23 Sales Of Approximatel...
08/04/2023 11:11:19

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION